Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

July 31, 2006

Conditions
Excessive Daytime SleepinessNarcolepsyObstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Interventions
DRUG

Armodafinil

Trial Locations (43)

19013

Crozer Chester Medical Center, Upland

19104

University of Pennsylvania, Philadelphia

19380

University Services, West Chester

20815

Center for Sleep and Wake Disorders, Chevy Chase

22182

Sleep Disorders Center of the Mid Atlantic, Vienna

28304

Cumberland Research Associates, Fayetteville

29201

SleepMed of South Carolina, Columbia

30342

Child Neurology Associates, PC, Atlanta

Neurotrials, Inc., Atlanta

31201

Sleepmed Inc., Macon

31405

Savannah Neuurology, Savannah

33707

Clinical Research Group of St. Petersburg, St. Petersburg

35213

Sleep Disorders Center of Alabama, Birmingham

35406

Neurology Consultants of Tuscaloosa, P.C., Tuscaloosa

37205

Sleep Medicine of Tennesse, Nashville

37813

Healthstar Physicians, Morristown

40217

Chest Medicine Assocaites d/b/a/ Sleep Medicine Specialists, Louisville

44122

North Coast Clinical Trials, Inc., Beechwood

44302

Neurology and Neuro Science Associates, Akron

50702

Convenant Clinic, Waterloo

60201

Evanston Northwestern Healthcare, Evanston Hospital, Evanston

72205

Neurology and Clinical Study Center, Little Rock

73109

Jonathan Schwartz, Oklahoma City

75013

Metroplex Pulmonary and Sleep Center, PA, Allen

75093

Sleep Medicine Associates of Texas, P.A, Plano

78258

Texas Association of Pediatric Neurology, San Antonio

78756

FutureSearch Trials, Austin

80113

Colorado Sleep Disorder Center, Englewood

85006

Pulmonary Associates, Phoenix

85032

HOPE Research Institute, Phoenix

85050

PsyPharm Clinical Research, Phoenix

85712

PsyPharm Clinical Research Inc., Tucson

90274

Penninsula Research Associates, Rolling Hills Estates

90806

West Coast Clinical Trials, Inc, Long Beach

91105

Neuro-Therapeutics, Inc, Pasadena

92801

Advanced Clinical Research Institute, Anaheim

93103

The Sleep Disorders Center of Santa Barbara, Santa Barbara

94109

Pacific Sleep Program, San Francisco

97209

Pacific Sleep Program, Portland

98034

Pacific Institute of Medical Science, Kirkland

98133

Pacific Institute of Mental Health, Seattle

02459

Neurocare. Inc, Newton

05452

Vermont Medical Sleep Disorders Center, Essex Junction

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00228566 - Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome | Biotech Hunter | Biotech Hunter